There are 2949 resources available
Q&A and live discussion
Presenter: Lori Pierce
Session: How can we reduce cancer numbers? (in collaboration with ASCO)
Resources:
Webcast
FGFR inhibitors
Presenter: Yohann Loriot
Session: New drugs in development: What will be approved in 2025?
Resources:
Slides
Webcast
Antibody Drug Conjugate (ADC)
Presenter: Victor Moreno Garcia
Session: New drugs in development: What will be approved in 2025?
Resources:
Slides
Webcast
Epigenetic drugs: EZH2, BET and LDSD1
Presenter: Sophie Postel-Vinay
Session: New drugs in development: What will be approved in 2025?
Resources:
Slides
Webcast
Future strategies of using radiotherapy as an immune-stimulating agent
Presenter: Fernanda Herrera
Session: New drugs in development: What will be approved in 2025?
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Rebecca Dent
Session: Recent updates in treatment strategies
Resources:
Webcast
Q&A and live discussion
Presenter: Jonathan Strosberg
Session: Peptide Receptor Radionuclide Therapy (PRRT) integration with other therapies
Resources:
Webcast
Q&A and live discussion
Presenter: Rolf Bjerkvig
Session: Blood-brain barrier
Resources:
Webcast
Q&A and live discussion
Presenter: Christophe Massard
Session: Applications of artificial intelligence (AI) in oncology drug development
Resources:
Webcast
Q&A and live discussion
Presenter: Susana Banerjee
Session: Checkpoint inhibitors and beyond in gynaecological cancers
Resources:
Webcast